OZAPIRA

Class [005]
Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, namely, Familial Mediterranean Fever (FMF), Neonatal Onset Multisystem Inflammatory Disease (NOMID), Tumor Necrosis Factor (TNF), Receptor-Associated Periodic Syndrome (TRAPS), Deficiency of the Interleukin-1 Receptor Antagonist (DIRA) and Behçet's Disease, autoimmune disease, namely rheumatoid arthritis, systemic lupus erythematosus, celiac sprue disease, pernicious anemia, vitiligo, scleroderma, psoriasis, inflammatory bowel diseases, Hashimoto's disease, Addison's disease, Graves' disease, reactive arthritis, Sjögren's syndrome, diabetes, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases, namely, psoriasis, rosacea, skin cancer, lupus, eczema, hives, leprosy, shingles, necrotizing fasciitis, carpal tunnel syndrome, tendonitis and arthritis; pharmaceutical preparations, namely, cytokine inhibitory drugs.